The sociodemographic characteristics of PSS patients and the control group.
| characteristics | Patients | Control | P-value |
|---|---|---|---|
| n (%) | |||
| Sex | |||
| Female | 31 (96.90) | 29 (96.70) | inevaluable |
| Male | 1 (3.10) | 1 (3.30) | |
| Age | |||
| n | 32 | 30 | 0.21 |
| % mean±SD | 45.84±9.39 | 42.8±9.52 | |
| median (min-max) | 46 (24-63) | 42 (28-64) | |
| Education n (%) | |||
| 5-8 years | 22 (68.80) | 20 (66.70) | 0.861 |
| >8 years | 10 (31.30) | 10 (33.30) | |
| Disease duration | 32 | ||
| % mean±SD | 3.45±3.75 | ||
| median (min-max) | 2.25 (0.25-18) | ||
| SS-A positive | 21 (67.70) | ||
| SS-B positive | 3 (9.70) | ||
| RO52 positive | 16 (51.60) | ||
| Drugs | |||
| Hydroxichloroqine | 29 (90.6) | ||
| Pilocarpine | 16 (50.0) | ||
| *NSAİD | 11 (34.4) | ||
| Prednisolone | 4 (12.5) | ||
| **other | 8 (25) | ||
| ***comorbidity | 9 (28) | ||